IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rapt Therapeutics Inc (RAPT)

CUSIP: 75382E208 | NYSE | Healthcare · Biotechnology | Small Cap | 118 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Vanguard Group Inc0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Vanguard Group Inc
0$00.0%N/AN/AValley Forge, PA2026-05-14